Because primary immunodeficiencies (PI) are rare, chronic conditions, continuity in our programs is one of the most important aspects of the services provided by the Immune Deficiency Foundation (IDF). Individuals living with PI, as well as their families, need to know that these services will be available throughout their lives. They need to know they can count on IDF.

To ensure this constancy, IDF is generously supported by organizations that provide a product or service to the PI community, understand the chronic nature of the disorders, and share the common goal to improve the quality of life for people with PI. Their support allows IDF to provide critical resources, educational materials, and local programming to individuals with PI, their families, and healthcare professionals free of charge.

The programming and strategic priorities of IDF are determined by an independent Board of Trustees, with input from our Medical Advisory Committee, and Nurse Advisory Committee, based on the needs of patients.

IDF greatly appreciates the commitment of our supporters and all others who make our mission possible.

IDF Core Service Leader
CSL Behring
Grifols
Takeda

IDF Core Service Supporter
Horizon Therapeutics

IDF Core Service Sustainer
Kedrion Biopharma
Accredo Healthcare

IDF Core Service Contributor
Pharming Healthcare
X4 Pharmaceuticals
AstraZeneca
Octapharma

IDF National Patron
Sumitomo Pharma America, Inc.
Chiesi Global Rare Diseases

Click here to review IDF's Partner Relationship statement.